Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
05/2008
05/02/2008WO2008050726A1 Novel fused-ring aromatic compound, process for producing the same, and use thereof
05/02/2008WO2008049922A2 A new process for the preparation of montelukast
05/01/2008US20080103180 CCR9 inhibitors and methods of use thereof
05/01/2008US20080103104 Benzamide precursor with sulfur substituent; poly-ADP-ribose polymerase inhibitors, antitumor agents; leukemia, breast, ovarian, lung, bladder, prostate, pancreatic, and cervical cancers
05/01/2008US20080103061 Functionalized compositions for improved immobilization
04/2008
04/30/2008EP1916236A1 Amide derivative, pesticide containing such compound and use thereof
04/30/2008CN101171326A 硫醇调味组分 Thiol flavoring ingredients
04/30/2008CN100384821C Cetp activity inhibitors
04/29/2008US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
04/29/2008US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/29/2008US7365069 Pyrimidone derivatives
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/24/2008WO2008047771A1 3-mercapto-2-alkanone and perfume composition containing the compound
04/24/2008WO2008047694A1 Process for production of benzothiazole compound
04/24/2008WO2002042261A8 PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES
04/24/2008US20080097125 Method for producing compound having fluorosulfonyl group by coupling reaction
04/24/2008US20080096962 tert-Butyl 2-{2-[1-ethyl-3-(4-trifluoromethoxy-phenyl)-ureido]-indan-5-ylsulfanyl}-2-methyl-propionate; peroximose proliferator activated receptor antagonist; cardiovascular desease, diabetes; coupling N(5mercapto-indan-2yl)acetamide with (2methyl-2halo) propionate and 2-(4-hydroxyphenoxy)propionic acid
04/24/2008US20080096942 Beta-secretase inhibitors; use in treating Alzheimer's disease; for example, N-{(1S,2R)-1-[3-(cyclohexylmethyl)benzyl]-2-hydroxy-3-[(3-methoxybenzyl)amino]propyl}acetamide hydrochloride
04/24/2008US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/24/2008DE102006049768A1 Producing 4-methylthio-2-hydroxybutyric acid comprises hydrolyzing 4-methylthio-2-hydroxybutyronitrile with sulfuric acid and hydrolyzing the resulting amide with a tertiary amine
04/24/2008DE102006049767A1 Producing 4-methylthio-2-hydroxybutyric acid comprises hydrolyzing 4-methylthio-2-hydroxybutyramide in the presence of a tertiary amine
04/23/2008EP1914225A1 Salt molten at room temperature and display device
04/23/2008EP1914223A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
04/23/2008EP1745006A4 Methods of 1,3-enyne preparation using copper (i) catalysts
04/23/2008EP0984928B1 Heterocyclic nitrato derivatives
04/23/2008CN101166836A Fungicidal compositions and methods using N-cyanodithiocarbimates
04/23/2008CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer
04/22/2008US7361786 Polymer enlarged ligands or complexes advantageous in catalytic processes carried out in a membrane reactor; high enantiomeric purity
04/22/2008US7361623 Trimerization of ethylene with a catalyst system comprising a coordination catalyst of a chromium source complexed with a di(alkylphosphinoalkyl)amino ligand, and an alumoxane; improved catalyst selectivity
04/17/2008WO2008044628A1 Process for production of peptide thioester
04/17/2008WO2008044033A1 Amide derivatives
04/17/2008US20080090959 Epoxide polymer surfaces
04/17/2008US20080090905 Antidiabetic agents; insulin resistance; dyslipidemias; dietetics
04/17/2008US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders
04/17/2008US20080090012 Aqueous boehmite particles of a hydrophilic polymer having a linked anchoring moiety which contains acid(s) and/or hydroxy(s); the polymeric moiety has a lower affinity for a boehmite surface than the anchoring moiety; mercaptosuccinic acid-modified polyacrylamide; ink jet; paper coating; gloss porousity
04/16/2008EP1911751A1 Amide derivative and pesticide containing such compound
04/16/2008EP1911740A1 Potassium channel modulators
04/16/2008EP1910282A1 Pleuromutilin derivatives useful as antibacterials
04/16/2008EP1910278A1 Amidonitrile compounds
04/16/2008EP1910272A1 Renin inhibitors
04/16/2008CN101161642A Method for decomposing chiral mobile phase additive RP-HPLC of fudosteine enantiomer
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/16/2008CN100381420C N-acetyl cysteine derivatives and use thereof
04/15/2008US7358359 Antibacterial agents
04/15/2008US7358264 Statine derivatives for the treatment of Alzheimer's disease
04/15/2008US7358248 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatases
04/15/2008CA2410303C Beta-amino acid nitrile derivatives
04/15/2008CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols
04/15/2008CA2154424C 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect
04/10/2008WO2008008701B1 Substituted cyclopentane derivatives as therapeutic agents
04/10/2008US20080085927 Peroxisome proliferator activated receptors; dyslipidemia; anticholesterol agents; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders; {4-[2-ethoxy-3-(4-trifluoromethyl-phenoxy)-propoxy]-2-methyl-phenoxy}-acetic acid
04/10/2008US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
04/09/2008EP1907405A1 Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity
04/09/2008CN101160285A Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as vr1 receptor antagonists
04/09/2008CN101157644A Method for preparing adamantine disulfide tetroxide derivative
04/09/2008CN100379775C Method for producing highly transparent plastics for optical materials
04/09/2008CN100379721C Preparations of a sulfinyl acetamide
04/08/2008US7355079 Thyronamine derivatives and analogs and methods of use thereof
04/08/2008US7355069 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations
04/08/2008US7354943 Statine derivatives for the treatment of Alzheimer's disease
04/03/2008WO2008009816A3 Aromatic sulfinates and sulfonyl halides, and the preparation thereof
04/03/2008US20080081807 Arylphenyl-substituted cyclic keto-enols
04/02/2008EP1904439A2 Sphingosine kinase inhibitors
04/02/2008EP1904428A2 New fluorinated compounds, their synthesis and use
04/02/2008EP1201648B1 Carbamate derivatives and agricultural/horticultural bactericides
04/02/2008CN101153016A Method for producing 3-(substituted phenyl) sulfur onium chloride salt
04/02/2008CN100378056C Luminous compounds and labeling reagents using the same
04/01/2008US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents
04/01/2008US7351857 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid; peroxisome proliferator activated receptors agonist; antidiabetic, dietetics, hypotensive and hypoglycemic agent; dyslipidemia
04/01/2008US7351742 Sulfonamide derivatives for the treatment of diseases
04/01/2008US7351721 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
03/2008
03/26/2008EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof
03/26/2008EP1902313A1 Trityl derivatives for enhancing mass spectrometry
03/26/2008EP1805137B1 Thiol compound and photosensitive composition using the same
03/26/2008EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases
03/26/2008EP1283826B1 A process for preparing carotenoid polyene chain compounds and intermediates for preparing the same
03/26/2008EP0971878B1 Amine compounds, their production and use as amyloid-beta production inhibitors
03/26/2008CN100376549C Malononitrile compounds and their use as pesticides
03/26/2008CN100376544C Insulated material monomer in aluminium and copper technology
03/25/2008US7348449 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
03/25/2008US7348319 amination of imidate bounded to (bio)polymer, aminoacid, or drug; reactions avoid direct contact with nitric oxide; substrate is medical device: stent, catheter, wound dressing, prosthesis, implant; restenosis, hypotensive agent, and impotency
03/25/2008CA2418770C Acylacetonitrile compound, process for preparation thereof, and miticide containing the same
03/25/2008CA2268709C Hiv protease inhibitors
03/20/2008WO2008032616A1 Oligoaniline compounds
03/20/2008WO2008012583A3 Cyclohexenone and cyclohexanone derivatives
03/20/2008US20080070956 ATPase inhibitors; Substituted fluorene or benzenerings joined to an alkylene through a sulfone or sulfoxide linkage; without excessive toxicity, irritation, allergic response etc.; sleep dioredrs like excessive sleepiness; Parkinson's disease; Alzheimer's disease; ADD; ADHA; depression, fatigue
03/20/2008DE102006039881A1 Aminofunktionelles Haftvermittlersystem für Edelmetalloberflächen Amino-functional coupling agent system for noble metal surfaces
03/19/2008EP1899302A1 Phenoxy acetic acids as ppar delta activators
03/19/2008CN101146766A Acyl hydrazides as kinase inhibitors, in particular for SGK
03/18/2008US7345188 preparing modafinil; benzhydrylthioacetate is prepared in a reaction medium comprising an organic solvent having an organic base or an inorganic basic salt; acetate thus produced is amidated and then oxidized
03/18/2008US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
03/18/2008US7345095 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester
03/18/2008CA2337280C A process for preparing substituted benzoyl cyanide amidinohydrazones
03/18/2008CA2295913C Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
03/18/2008CA2237279C Liquid polyfunctional additives
03/18/2008CA2225206C Aminophenyl ketone derivatives and a method for the preparation thereof
03/13/2008WO2008030883A2 Treatment of cancer
03/13/2008WO2008028845A1 Perfluoroalkyl substituted phenol derivatives as surface modifiers
03/13/2008US20080064606 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 272